Global
Data’s clinical trial report, Pathological
Gambling Global Clinical Trials Review, H1, 2018" provides an
overview of Pathological Gambling clinical trials scenario. This report
provides top line data relating to the clinical trials on Pathological
Gambling. Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe. The report offers
coverage of disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also provides
prominent drugs for in progress trials (based on number of ongoing trials).
GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary
database Pharma eTrack Clinical trials database. Clinical trials are collated
from 80+ different clinical trial registries, conferences, journals, news etc
across the globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create an
effective counter strategies to gain competitive advantage.
The
report provides a snapshot of the global clinical trials landscape
Report
provides top level data related to the clinical trials by Region, Country (G7
& E7), Trial Status, Trial Phase, Sponsor Type and End point status
The
report reviews top companies involved and enlists all trials (Trial title,
Phase, and Status) pertaining to the company
The
report provides all the unaccomplished trials (Terminated, Suspended and
Withdrawn) with reason for unaccomplishment
The
Report provides enrollment trends for the past five years
Report
provides latest news for the past three months
Assists
in formulating key business strategies with regards to investment
Helps
in identifying prominent locations for conducting clinical trials which saves
time and cost
Provides
top level analysis of Global Clinical Trials Market which helps in identifying
key business opportunities
Supports
understanding of trials count and enrollment trends by country in global
therapeutics market
Aids
in interpreting the success rates of clinical trials by providing a comparative
scenario of completed and uncompleted (terminated, suspended or withdrawn)
trials
Facilitates
clinical trial assessment of the indication on a global, regional and country
level
To know more click on the link below:
Contact Us:
Ken
Research
Ankur
Gupta, Head Marketing & Communications
0124-4230204